Skip to main content
ArticleOPEN ACCESS

CMV: Persistent nemesis for SCT

Blood
DOI: 10.1182/blood-2016-03-701672
1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Teira et al have shown, in a large database analysis, that cytomegalovirus (CMV) still kills stem cell transplant recipients but does not prevent relapse of malignancy.

Cite

CITATION STYLE

APA

Feuchtinger, T. (2016, May 19). CMV: Persistent nemesis for SCT. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-03-701672

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free